ESG Sustainability Report

Overview

The report describes PharmaEssentia's 2023 global expansion, including consolidated turnover of NT$5.106 billion and a workforce of 559 employees worldwide. It adopts a double materiality approach and places Board-level oversight over sustainability matters. Environmental disclosures cover TCFD climate action, Scope 1-3 inventory work, energy management, water stewardship, and waste, including 33.8 metric tons of waste generated. The report also documents employee well-being, diversity, patient access initiatives, and independent assurance by AFNOR Asia Ltd.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview